Similarities and contrasts in ryanodine receptor localization and function in osteoclasts and striated muscle cells

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 255-270

  Huang, Christopher L H ^a   Sun, Li ^b   Fraser, James A ^a   Grace, Andrew A ^a   Zaidi, Mone ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Cardiac muscle; Osteoclasts; Ryanodine receptor; Skeletal muscle

Indexed keywords

CAFFEINE; CALCIUM; CALCIUM CHANNEL L TYPE; DANTROLENE; PERCHLORATE; RUTHENIUM RED; RYANODINE; RYANODINE RECEPTOR;

BINDING AFFINITY; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL TYPE; CONFERENCE PAPER; MEMBRANE POTENTIAL; MUSCLE CELL; NONHUMAN; OSTEOCLAST; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

EID: 37349024756     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.064     Document Type: Conference Paper

References (84)

1. BERRIDGE, M.J. 1993. Inositol trisphosphate and calcium signalling. Nature 361: 315-325.
2. 2+ release channels and their regulation by endogenous effectors. Annu. Rev. of Physiol. 56: 485-508.
3. BERS, D.M. 2002. Cardiac excitation-contraction coupling. Nature 415: 198-205.
4. WEHRENS, X.H., S.E. LEHNART, S.R. REIKEN, et al. 2004. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304: 292-296.
5. 2+ leak through ryanodine receptor in heart failure. Circulation 102: 2131-2136.
6. 2+ handling in heart failure. J. Clin. Invest. 115: 556-564.
7. ZHANG, L., J. KELLEY, G. SCHMEISSER, et al. 1997. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J. Biol. Chem. 272: 23389-23397.
8. HUANG, C.L.-H. 1990. Voltage-dependent block of charge movement components by nifedipine in frog skeletal muscle. J. Gen. Physiol. 96: 535-558.
9. HUANG, C.L.-H. 1993. Intramembrane Charge Movements in Skeletal Muscle. Oxford University Press. Oxford.
10. SCHNEIDER, M.F. & W.K. CHANDLER. 1973. Voltage-dependent charge in skeletal muscle: a possible step in excitation-contraction coupling. Nature 342: 244-246.
11. NAKAI, J., R.T. DIRKSEN, H.T. NGUYEN, et al. 1996. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 380: 72-75.
12. HUANG, C.L.-H. 1996. Kinetic isoforms of intramembrane charge in intact amphibian striated muscle. J. Gen. Physiol. 107: 515-534.
13. HUANG, C.L.-H. 1997. Dual actions of tetracaine on intramembrane charge in amphibian skeletal muscle. J. Physiol. 501: 589-606.
14. HUANG, C.L.-H. 1998. The influence of caffeine on intramembrane charge movements in intact frog striated muscle. J. Physiol. 512: 707-721.
15. FABIATO, A. 1985. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J. Gen. Physiol. 85: 247-289.
16. CANNELL, M. B, H. CHENG & W.J. LEDERER. 1995. The control of calcium release in heart muscle. Science 268: 1045-1049.
17. WEHRENS, X.H., S.E. LEHNART, T. HUANG, et al. 2003. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113: 829-840.
18. KONTULA, K., P.J. LAITINEN, A. LEHTONEN, et al. 2005. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc. Res. 67: 379-387.
19. YANO, M., T. YAMAMOTO, N. IKEMOTO & M. MATSUZAKI. 2005. Abnormal ryanodine receptor function in heart failure. Pharmacol. Ther. 107: 377-391.
20. PHROMMINTIKUL, A. & N. CHATTIPAKORN. 2006. Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death. Int. J. Cardiol. 112: 142-152.
21. TANABE, T., K.G. BEAM, J.A. POWELL & S. NUMA. 1988. Restoration of excitation contraction coupling and slow Ca current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature 336: 134-139.
22. TANABE, T., A. MIKAMI, S. NUMA & K.G. BEAM. 1990. Cardiac-type excitation contraction coupling in dysgenic skeletal muscle injected with cardiac dihydropyridine receptor cDNA. Nature 344: 451-453.
23. Tanabe, T., K.G. Beam, B.A. Adams, et al. 1990. Regions of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 346: 567-569.
24. TAKESHIMA, H., M. IINO, H. TAKEKURA, et al. 1994. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369: 556-559.
25. 2+ signal amplification in excitation-contraction coupling. EMBO J. 15: 6172-6177.
26. NAKAI, J., T. OGURA, F. PROTASI, et al. 1997. Functional nonequality of the cardiac and skeletal ryanodine receptors. Proc. Natl. Acad. Sci. USA 94: 1019-1022.
27. LIPP, P. & E. NIGGLI. 1993. Microscopic spiral waves reveal positive feedback in subcellular calcium signalling. Biophys. J. 65: 2272-2276.
28. i waves in cardiac myocytes. Am. J. Physiol. 270: C148-C159.
29. CHAWLA, S., J.N. SKEPPER, A.R. HOCKADAY & C.L.-H. HUANG. 2001. Calcium waves induced by hypertonic solutions in intact frog skeletal muscle fibres. J. Physiol. 536: 351-360.
30. KLEIN, M.G., H. CHENG, L.F. SANTANA, et al. 1996. Two mechanisms of quantized calcium release in skeletal muscle. Nature 379: 455-458.
31. 2+ release (SOICR). Proc. Natl. Acad. Sci. USA 101: 13062-13067.
32. PRIORI, S.G., C. NAPOLITANO, N. TISO, et al. 2001. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103: 196-200.
33. WEHRENS, X.H. & A.R. MARKS. 2003. Altered function and regulation of cardiac ryanodine receptors in cardiac disease. Trends Biochem. Sci. 28: 671-678.
34. FRANCIS, J., V. SANKAR, V.K. NAIR & S.G. PRIORI. 2005. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2: 550-554.
35. GEORGE, C.H., H. JUNDI, N. L THOMAS, et al. 2007. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies. J. Mol. Cell Cardiol. 42: 34-50.
36. ROSEN, M.R. & P. DANILO JR. 1980. Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666 on ouabain-induced delayed afterdepolarizations in canine Purkinje fibers. Circ. Res. 46: 117-124.
37. LEENHARDT, A., V. LUCET, I. DENJOY, et al. 1995. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91: 1512-1519.
38. KUMMER, J.L., R. NAIR & S.C. KRISHNAN. 2006. Images in cardiovascular medicine. Bidirectional ventricular tachycardia caused by digitalis toxicity. Circulation 113: e156-e157.
39. CERRONE, M., B. COLOMBI, M. SANTORO, et al. 2005. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ. Res. 96: e77-e82.
40. SILVER, I.A., R.J. MURRILLS & D.J. ETHERINGTON. 1988. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175: 266-276.
41. MALGAROLI, A., J. MELDOLESI, A.Z. ZALLONE & A. TETI. 1989. Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J. Biol. Chem. 264: 14342-14347.
42. ZAIDI, M., H. K DATTA, A. PATCHELL, et al. 1989. 'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem. Biophys. Res. Commun. 163: 1461-1465.
43. DATTA, H.K., I. MACINTYRE & M. ZAIDI. 1989. The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts. Biosci. Reports 9: 747-751.
44. MOONGA, B.S., D.W. MOSS, A. PATCHELL & M. ZAIDI. 1990. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J. Physiol. 429: 29-45.
45. ZAIDI, M. 1990. "Calcium receptors" on eukaryotic cells with special reference to the osteoclast. Biosci. Reports 10: 493-507.
46. DATTA, H.K., I. MACINTYRE & M. ZAIDI. 1990. Intracellular calcium in the control of osteoclast function. I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazem. Biochem. Biophys. Res. Commun. 167: 183-188.
47. BROWN, E.M., G. GAMBA, I.D. RICCARDI, et al. 1993. Cloning and characterization of an extracellular calcium sensing receptor from bovine parathyroid. Nature 366: 575-579.
48. 2+-sensing receptors in intestinal epithelium. Am. J. Physiol. 273: C1168-C1175.
49. PAZIANAS, M., O.A. ADEBANJO, V.S. SHANKAR, et al. 1995. Extracellular cation sensing by the enterocyte. Prediction of a novel divalent cation "receptor". Biochem. Biophys. Res. Commun. 210: 948-953.
50. RICCARDI, D., J. PARK, W.S. LEE, et al. 1995. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc. Natl. Acad. Sci. USA 92: 131-135.
51. 2+-sensing receptor: a target for polyamines. Am. J. Physiol. 273: C1315-C1323.
52. LUNDGREN, S., G. HJALM, P. HELLMAN, et al. 1994. A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belongs to the LDL-receptor protein superfamily. Exp. Cell Res. 212: 344-350.
53. 2+ and other ions as extracellular (first) messengers. Physiol. Rev. 71: 371-411.
54. 2+-sensing receptor. J. Physiol. 513: 399-410.
55. ZAIDI, M., J. KERBY, C.L.-H. HUANG, et al. 1991. Divalent cations mimic the inhibitory effects of extracellular ionized calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor". J. Cell. Physiol. 149: 422-427.
56. ZAIDI, M., V.S. SHANKAR, C.M.R. BAX, et al. 1992. Characterization of the osteoclast calcium receptor. In Calcium Regulation and Bone Metabolism. D.V. Cohn & A.R. Tashjian Jr., Eds.: 170-174. Elsevier. Amsterdam.
57. 3+. Biochem. Biophys. Res. Commun. 187: 907-912.
58. 2+ receptor is highly sensitive to activation by transition metal cations. Biochem. Biophys. Res. Commun. 187: 913-918.
59. BAX, C.M., V.S. SHANKAR, B.S., MOONGA, et al. 1992. Is the osteoclast calcium "receptor" a receptor-operated calcium channel? Biochem. Biophys. Res. Commun. 183: 619-625.
60. 2+ receptor. Exp. Physiol. 78: 517-529.
61. ZAIDI, M., V.S. SHANKAR, A.S. TOWHIDUL ALAM, et al. 1992. Evidence that a ryanodine receptor triggers signal transduction in the osteoclast. Biochem. Biophys. Res. Commun. 188: 1332-1336.
62. 2+ redistribution and divalent cation modulation. J. Cell. Physiol. 155: 120-129.
63. HUANG, C.L.-H. 1986. The differential effects of twitch potentiators on charge movements in frog skeletal muscle. J. Physiol. 380: 17-33.
64. HUANG, C.L.-H. 1987. "Off" tails of intramembrane charge movements in frog skeletal muscle in perchlorate-containing solutions. J. Physiol. 384: 492-509.
65. MOONGA, B.S., H.K. DATTA, P.J.R. BEVIS, et al. 1991. Correlates of osteoclast function in the presence of perchlorate ions in the rat. Exp. Physiol. 76: 923-933.
66. MIYAUCHI, M., K.A. HRUSKA, E.M. GREENFIELD, et al. 1990. Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption. J. Cell Biol. 111: 2543-2552.
67. 2+ release. Am. J. Physiol. 268: F447-F454.
68. 2+ sensor. J. Clin. Investig. 96: 1582-1590.
69. 2+ in isolated rat osteoclasts. Am. J. Physiol. 270: F469-F475.
70. 2+ release channel complex. J. Biol. Chem. 264: 1329-1335.
71. KAMEDA, T., H. MANO, Y. YAMADA, et al. 1998. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem. Biophys. Res. Commun. 245: 419-422.
72. 2+ in rat osteoclasts in the presence of thapsigargin. J. Bone Min. Res. 8: 961-967.
73. ZAIDI, M., A.S.M.T. ALAM, V.S. SHANKAR, et al. 1993. Cellular biology of bone resorption. Biol. Rev. Camb. Philos. Soc. 68: 197-264.
74. MOONGA, B.S., R. DAVIDSON, L. SUN, et al. 2001. Identification and characterization of a sodium/calcium exchanger, NCX-1, in osteoclasts and its role in bone resorption. Biochem. Biophys. Res. Commun. 283: 770-775.
75. SUN, L., O.A. ADEBANJO, B.S. MOONGA, et al. 1999. CD38/ADP-ribosyl cyclase: a new role in the regulation of osteoclastic bone resorption. J. Cell Biol. 146: 1161-1171.
76. 2+ sensing in the regulation of osteoclastic bone resorption. J. Cell Biol. 142: 1347-1356.
77. 2+ sensing at low physiological concentrations. Biochem. Biophys. Res. Commun. 249: 668-671.
78. 2+ sensing and extracellular acidification. Biochem. Biophys. Res. Commun. 194: 742-747.
79. 2+ homeostasis. Nat. Cell Biol. 7: 409-414.
80. 2+ from the nuclear envelope. Cell 80: 439-444.
81. SANTELLA, L. & E. CARAFOLI. 1997. Calcium signaling in the cell nucleus. FASEB J. 11: 1091-2109.
82. BELLIDO, T., N. STAHL, T.J. FARRUGGELLA, et al. 1996. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J. Clin. Investig. 97: 431-437.
83. FRANCHIMONT, N., S. RYDZIEL & E. CANALIS. 1997. Interleukin-6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J. Clin. Investig. 100: 1797-1803.
84. 2+: physiological regulation and role in apoptosis. Mol. Cell. Biochem. 135: 89-98.